Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)

Q: What does CUSIP 501976104 represent in this 13F holders report?

CUSIP 501976104 is the security identifier for KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share in Q3 2025?

74 institutional investors reported KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 501976104

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock, par value $0.00001 per share
Total 13F shares: 22,688,863
Total 13F value: $136,134,153
Share change: -540,862
SEC-reported price per share: $6.00
Number of holders: 74
Value change: -$2,158,017
Number of buys: 27
Number of sells: 42
Shares outstanding: 61,864,407

Security key

501976104

Report period

Q3 2025

Institutions

Top holders

KYTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Kyverna Therapeutics, Inc. SEC filings Kyverna Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 501976104

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

GILEAD SCIENCES, INC.

Disclosed value leader

Vida Ventures Advisors, LLC

Comparable rows

0/15

Latest evidence

30 Jun 2025

13F 3/4/5 Highest disclosed value: $13,888,447 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Vida Ventures Advisors, LLC has the largest disclosed position value at $13.89M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vida Ventures Advisors, LLC's linked filing trail.

Disclosed position value Top 5

GILEAD SCIENCES, INC. $12.67M

Bain Capital Life Sciences Invest... $10.34M

Vida Ventures Advisors, LLC $13.89M

PRICE T ROWE ASSOCIATES INC /MD/ $5.62M

VANGUARD GROUP INC $4.03M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GILEAD SCIENCES, INC.	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$12,667,185 4,126,119 shares	—	30 Jun 2025
Bain Capital Life Sciences Investors, LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$10,340,896 3,368,370 shares	—	30 Jun 2025
Vida Ventures, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 4,777,060 shares	—	12 Feb 2024
Northpond Ventures III GP, LLC	3/4/5 Former 10% Owner 3/4/5	— denominator unverified	— 3,255,426 shares	—	12 Feb 2024
Westlake BioPartners Fund I, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 735,984 shares	—	12 Feb 2024
Vida Ventures Advisors, LLC	13F Company 13F	— denominator unverified	$13,888,447 4,523,924 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

22,688,863

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

-3

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend